Patient 4 had an ER-positive, PR-negative, HER2-positive (IHC score, 2+; FISH ratio, 2.6) left-breast IDC diagnosed in 2019, with metastatic disease to the bones. The gene discussed is ERBB2; the disease is metastatic neoplasm.